Abstract:Background Transforming growth factor beta (TGF-beta) plays an essential role in the regulation of normal physiologic processes of cells. TGF-beta has been shown to regulate several mitogen-activated protein kinases (MAPK) pathways in several epithelial cells. However, the effects of TGF-beta on soft tissue sarcoma are seldom reported. Our previous studies suggested that there should be some other signal transduction pathways besides Smads, which are important to regulate the growth of human embryonal rhabdomyosarcoma (RMS) cells. In the present study, we examined the expression and functional relations of extracellular signal-regulated kinase 2 (ERK2) and Smad4 in human RMS tissue and a RMS cell line, RD.Methods RD cells and normal human primary skeletal myoblasts (Mb) were treated with TGF-betal to establish the expression profile of ERK2 at the mRNA and protein levels detected by RT-PCR and immunofluorescence. Immunohistochemistry was used to detect the expression of ERK2 and Smad4 in 50 tissue specimens of human RMS and 23 specimens of normal skeletal muscles. Follow-up of specimens was performed 6 months to 70 months later.Results RD cells and human RMS tissues showed the higher expression of ERK2 and Smad4 than the normal control, either the protein level or the mRNA level. And, exogenous TGF-betal stimulation can lead to higher expression of ERK2 and its nuclear translocation, so TGF-beta1 can also activated MAPK (ERK2) pathway, resulting in a sustained activation of ERK2 for at least 2 hours. Immunohistochemistry analysis, however, showed that there was no correlation between ERK2 and Smad4 protein. The overexpression of ERK2 and Smad4 had no indicative effects on histological subtypes, histological grading, gender, age, and prognosis.Conclusions In RMS, signaling of TGF-beta1 from cell surface to nucleus can also be directed through the MAPK (ERK2) pathway besides the TGF-beta1/Smads pathway. The activation of ERK2 by TGF-beta1 may be Smad4 independent. Moreover, there may be some other tanglesome relationships between the TGF-beta1/Smads pathway and the MAPK pathway which takes part in the development, invasion and metastasis of tumor cells.

Smad4 Participates in the TGF--#beta#1--mediated ERK/MAPK Signaling Pathway

Smad4 Participates in the TGF-β1-mediated ERK/MAPK Signaling Pathway

Regulatory effect of Smad7 gene on MAPK signal pathway in malignant transformation of immortalized human bronchial epithelial BEP2D cells]

Identification Of The Gene Transcription And Apoptosis Mediated By Tgf-Beta-Smad2/3-Smad4 Signaling

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Smad4 And Erk2 Stimulated By Transforming Growth Factor Betal In Rhabdomyosarcoma

Smad-independent pathway involved in transforming growth factor β1-induced Nox4 expression and proliferation of endothelial cells

Smad4 and ERK2 Stimulated by Transforming Growth Factor Beta1 in Rhabdomyosarcoma.

Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor β-induced epithelial-mesenchymal transition.

Overexpression of Smad2 Reveals Its Concerted Action with Smad4 in Regulating TGF- β-Mediated Epidermal Homeostasis

The Tumor Suppressor Smad4/Dpc4 and Transcriptional Adaptor Cbp/P300 Are Coactivators for Smad3 in Tgf-Beta-Induced Transcriptional Activation

Targeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure

Functional Characterization of Transforming Growth Factor Β Signaling in Smad2- and Smad3-deficient Fibroblasts*

P42/p44 ERK Modulates TGF-β1-mediated Phosphorylation and Translocation in Cardiac Myofibroblasts

Kruppel‐like factor 4 is involved in TGF‐beta1‐induced VSMC differentiation through trans‐activating TbetaRI expression

Participation of Smad2, Smad3, and Smad4 in Transforming Growth Factor β (TGF-β)-induced Activation of Smad7

Effect of Smad7 on the Expression of TGF-βR, SMADs, and STRAP in the Process of Malignant Transformation of Human Bronchial Epithelial Cells

Smad4 is A Potential Prognostic Marker in Human Breast Carcinomas

Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β

Mtmr4 Attenuates Transforming Growth Factor Beta (Tgf Beta) Signaling By Dephosphorylating R-Smads In Endosomes

Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4